Q&A with Lunglife AI's CEO, Paul Pagano
Episode 1568, Aug 08, 2023, 09:51 AM
(Watch video interview HERE)
In this interview, Paul Pagano CEO of Lunglife AI (LLAI ) takes Vox through today’s ‘in line’ H1’23 results and the next steps wrt commercialising its ground-breaking early stage lung cancer blood test.
00:00 - How the LungLB diagnostic works, and what problem it solves.
03:55 - Its accuracy vs the existing standard of care.
05:25 - Size of addressable market.
09:45 - Progress of 425 person validation trial.
11:05 - Significance of the LungLB peer reviewed pilot study & cost-effectiveness health economics report.
13:50 - Commercialisation strategy.
19:45 - Future R&D roadmap.
21:20 - Funding runway & long term opportunity
In this interview, Paul Pagano CEO of Lunglife AI (LLAI ) takes Vox through today’s ‘in line’ H1’23 results and the next steps wrt commercialising its ground-breaking early stage lung cancer blood test.
00:00 - How the LungLB diagnostic works, and what problem it solves.
03:55 - Its accuracy vs the existing standard of care.
05:25 - Size of addressable market.
09:45 - Progress of 425 person validation trial.
11:05 - Significance of the LungLB peer reviewed pilot study & cost-effectiveness health economics report.
13:50 - Commercialisation strategy.
19:45 - Future R&D roadmap.
21:20 - Funding runway & long term opportunity